SciELO - Scientific Electronic Library Online

 
vol.33 número2Candida parapsilosis: principal causa de candidemia en un hospital de referencia para adultos de Costa RicaDuración del tratamiento y administración oral de antimicrobianos en neumonía adquirida en la comunidad índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

AGUAYO, Alejandro et al. Colistin in the post-antibiotic era. Rev. chil. infectol. [online]. 2016, vol.33, n.2, pp.166-176. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182016000200006.

One of the most important features of the post-antibiotic era in the late 20th century is the resurgence of colistin for the treatment of extensively drug resistant gram-negative bacteria (XDR). Colistin is a narrow spectrum anti-biotic, active against microorganisms with clinical significance such as Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae. Nowadays its toxicity is lower, partly explained by better pharmaceuticals and management of the critically ill patients. However, there has been much confusion regarding the dosage of the drug, its name and labeling, therefore, experts have recommended using a common language about this polymyxin. The lack of PK/PD studies for colistin is perhaps the main weakness of this area of knowledge, even though the before mentioned approach has contributed with new ways to manage and calculate the dose of this antimicrobial. Indeed, the efficiency of colistin in association with a second agent in reducing mortality has not been demonstrated.

Palabras clave : Colistin; polymyxin; post-antibiotic era; bacterial drug-resistance; structure-activity relationship; combination therapy.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons